stockrow
Friday 6 November 2026
Export BWAY’s income statement to Excel — free account
Brainsway Ltd. Sponsored ADR
BWAY Healthcare Medical Devices
Brainsway Ltd. Sponsored ADR’s revenue for fiscal 2025 (year ended December 2025) was $52.2 million, up 27.3% from fiscal 2024.
- Revenue
- +35.4%
- EPS
- +40.0%
- Free cash flow
- −51.7%
Quarter to June 2026, against a year earlier
11.14
0.53
+5.00%
Follow BWAY
Alert me
| Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | 3 | 6 | 2 | 6 | 7 | 6 |
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 55.47 | 23.78 |
Altman Z-Score |
— | — | — | 2.09 | 1.15 | 3.43 | (0.13) | 1.88 | 2.84 | 2.82 |
P/S ratio |
5.35 | 5.35 | 5.35 | 4.33 | 3.84 | 4.04 | 1.38 | 3.77 | 3.90 | 3.46 |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 24.63 | 11.93 |
Altman Z″-Score (non-manufacturers) |
(4.43) | — | (8.10) | (2.03) | (3.55) | 4.10 | 1.35 | 1.03 | 3.22 | 3.11 |
Beneish M-Score |
— | — | — | (2.44) | (3.43) | (1.99) | (2.92) | (2.77) | (1.75) | (2.45) |
P/Operating CF |
(101.62) | (101.62) | (101.62) | (81.27) | 51.61 | 33.57 | (16.69) | 48.38 | 45.84 | (139.98) |
P/B ratio |
17.78 | 17.78 | 17.78 | 4.13 | 4.31 | 2.09 | 0.82 | 2.88 | 2.57 | 2.47 |
Price to Tangible BV |
17.78 | 17.78 | 17.78 | 4.13 | 4.31 | 2.09 | 0.82 | 2.88 | 2.57 | 2.47 |
EV/Sales |
5.08 | 5.08 | 5.08 | 3.50 | 3.19 | 2.21 | (0.28) | 2.40 | 2.28 | 2.19 |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.68 | 0.00 | 29.54 | 19.48 |
EV/Operating CF |
(22.31) | (22.31) | (22.31) | (11.17) | (48.97) | 74.05 | 0.77 | 59.42 | 9.07 | 6.53 |
EV/FCF |
(15.31) | (15.31) | (15.31) | (7.67) | (18.01) | (48.34) | 0.97 | (69.17) | 14.36 | 7.54 |
Quick Ratio |
2.98 | 2.91 | 1.62 | 4.29 | 3.35 | 7.02 | 6.47 | 5.13 | 4.84 | 3.27 |
Current Ratio |
2.98 | 2.92 | 1.62 | 4.29 | 3.57 | 7.22 | 7.14 | 5.68 | 5.19 | 3.73 |
Net Debt/EBITDA |
5.16 | 1.90 | 1.60 | 3.85 | 5.35 | 17.31 | 4.29 | 12.77 | (22.02) | (11.84) |
Debt/Assets |
0.00% | 0.00% | 12.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 0.21 | 0.41 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.47 | 1.11 | 0.75 | 0.74 | 0.61 | 0.54 | 0.39 | 0.50 | 0.52 | 0.50 |
Operating CF/Net income |
1.00 | 0.51 | 0.58 | 0.70 | 0.27 | (0.14) | 0.73 | (0.31) | 3.53 | 2.31 |
Capex/Depreciation |
0.00 | 0.00 | (1.61) | (1.18) | (1.53) | (1.33) | 1.26 | (1.79) | (2.14) | (1.52) |
Interest Coverage |
(69.68) | (90.85) | (121.22) | (47.04) | (73.89) | (3.52) | (8.64) | (4.28) | 0.92 | 1.96 |
| (20.80%) | (61.24%) | (65.85%) | (66.26%) | (24.56%) | (16.79%) | (25.99%) | (9.65%) | 5.62% | 11.18% | |
| (10.19%) | (70.51%) | (29.71%) | (33.14%) | (14.80%) | (11.78%) | (19.04%) | (6.59%) | 3.71% | 7.30% | |
ROIC |
0.00% | 0.00% | (446.40%) | (227.85%) | (123.09%) | 0.00% | 0.00% | 0.00% | 0.00% | 71.48% |
Return on Tangible Assets |
(15.39%) | (37.41%) | (80.24%) | (39.18%) | (19.91%) | (9.83%) | (24.14%) | (8.15%) | 4.13% | 11.05% |
Average Days of Receivables |
110.85 | 109.15 | 98.15 | 109.56 | 92.37 | 77.93 | 65.06 | 43.41 | 40.90 | 28.73 |
Research and Development Expense of Revenue |
34.00% | 49.89% | 37.54% | 34.09% | 26.40% | 21.56% | 28.25% | 20.97% | 17.53% | 18.39% |
Selling, General and Administrative Expense of Revenue |
66.30% | 91.69% | 71.76% | 80.39% | 72.56% | 73.05% | 92.18% | 68.49% | 53.64% | 48.75% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 4.33% | 5.47% | 3.62% | 6.38% | 5.42% | 1.20% | 3.51% | 2.29% |
Graham Net Nets |
(0.07) | (0.07) | (0.07) | 0.14 | 0.12 | 0.39 | 1.04 | 0.28 | 0.30 | 0.24 |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.75 | 5.89 |
Earnings Yield |
(7.92%) | (7.92%) | (7.92%) | (10.33%) | (6.37%) | (5.19%) | (35.24%) | (3.51%) | 1.80% | 4.21% |
Free Cash Flow Yield |
(6.20%) | (6.20%) | (6.20%) | (10.56%) | (4.61%) | (1.13%) | (20.90%) | (0.92%) | 4.06% | 8.38% |
Revenue per Share |
1.52 | 1.50 | 1.97 | 2.25 | 1.96 | 1.90 | 1.65 | 1.92 | 2.41 | 2.75 |
Operating CF per Share |
(0.33) | (0.49) | (0.45) | (0.71) | (0.13) | 0.06 | (0.59) | 0.08 | 0.61 | 0.92 |
Capex per Share |
0.00 | 0.00 | (0.24) | (0.32) | (0.22) | (0.14) | 0.12 | (0.14) | (0.22) | (0.12) |
Free Cash Flow per Share |
(0.33) | (0.49) | (0.69) | (1.03) | (0.35) | (0.09) | (0.47) | (0.07) | 0.38 | 0.80 |
Cash per Share |
1.35 | 1.97 | 1.09 | 2.14 | 1.53 | 3.68 | 2.90 | 2.79 | 4.10 | 3.65 |
Shareholders Equity per Share |
1.42 | 1.72 | 0.84 | 2.36 | 1.75 | 3.68 | 2.75 | 2.51 | 3.67 | 3.85 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
1.42 | 1.72 | 0.84 | 2.36 | 1.75 | 3.68 | 2.75 | 2.51 | 3.67 | 3.85 |
Free Cash Flow |
(2.40) | (3.59) | (5.74) | (10.55) | (3.91) | (1.35) | (7.82) | (1.10) | 6.50 | 15.15 |
Working Capital |
8.73 | 11.76 | 5.14 | 22.11 | 17.50 | 56.38 | 49.95 | 45.70 | 64.32 | 61.33 |
Capital Expenditures |
(0.41) | (1.02) | (1.97) | (3.31) | (2.47) | (2.24) | 1.94 | (2.39) | (3.79) | (2.34) |
Net Current Asset Value |
8.36 | 8.61 | (3.17) | 14.31 | 9.92 | 47.04 | 39.01 | 34.07 | 47.67 | 43.80 |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.60 | 0.00 | 67.15 | 26.42 |
Capex to Sales |
0.00 | 0.00 | 0.12 | 0.14 | 0.11 | 0.08 | (0.07) | 0.08 | 0.09 | 0.04 |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 115.14 | 41.80 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.09 | 0.16 | 0.42 | 0.66 | 0.17 | 0.18 | 0.29 | 0.23 | 0.28 | 0.21 |
Cash ROIC |
(11.95%) | (11.97%) | (30.47%) | (22.89%) | (10.61%) | (1.18%) | (8.39%) | (1.26%) | 4.93% | 10.63% |
Accounts Receivable Turnover |
3.32 | 3.32 | 4.25 | 4.07 | 3.52 | 4.98 | 4.86 | 7.37 | 9.79 | 12.00 |
Accounts Payable Turnover |
2.05 | 2.25 | 1.85 | 2.88 | 4.81 | 7.01 | 6.43 | 8.87 | 5.76 | 4.85 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 2.20 | 2.56 | 2.35 |
Average Days of Payables |
118.05 | 216.82 | 228.11 | 93.94 | 56.36 | 60.95 | 57.14 | 33.30 | 100.32 | 69.03 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 196.45 | 163.30 | 154.81 | 185.44 |
Average Receivables |
3.33 | 3.33 | 3.86 | 5.67 | 6.26 | 5.96 | 5.59 | 4.31 | 4.19 | 4.35 |
Average Payables |
1.22 | 1.22 | 1.94 | 1.78 | 1.05 | 0.94 | 1.11 | 0.94 | 1.81 | 2.65 |
Average Inventory |
— | — | — | — | — | — | — | 3.78 | 4.07 | 5.47 |
Average Assets |
23.53 | 10.00 | 21.81 | 31.17 | 36.37 | 54.87 | 70.10 | 63.72 | 78.64 | 103.75 |
Average Common Equity |
11.52 | 11.52 | 9.84 | 15.59 | 21.93 | 38.48 | 51.36 | 43.49 | 51.95 | 67.74 |
Columns are period end dates · fundamentals updated 26 Oct 2026